Table 2. Target proteins, acetylated proteins in group treated with diacetyl but non-acetylated in control group.
| Protein I.D. | Gene I.D. | Meta score control | Meta score treated | Peptides control | Peptides treated | *SC [%] control | *SC [%] treated |
|---|---|---|---|---|---|---|---|
| AL1A1_RAT | AL1A1 | 269.1 | 253.5 | 11 | 9 | 37.1 | 31.7 |
| ANXA2_RAT | ANXA2 | 539.6 | 284.6 | 13 | 13 | 44.5 | 43.7 |
| ANXA5_RAT | ANXA5 | 411 | 265 | 10 | 10 | 37.3 | 43.6 |
| ASSY_RAT | ASS1 | 71 | 1,030.1 | 3 | 21 | 20.6 | 64.3 |
| BHMT1_RAT | BHMT1 | 172.3 | 834.8 | 7 | 24 | 30 | 63.1 |
| CALR_RAT | CARL | 277.1 | 607.2 | 8 | 13 | 31.7 | 49.5 |
| CES1D_RAT | CES1D | 598.6 | 571.1 | 15 | 16 | 38.8 | 50.8 |
| DYH1_RAT | DNAHC1 | 1,391.9 | 1,603.7 | 77 | 89 | 23.5 | 27.7 |
| EF2K_RAT | EEF2K | 354 | 304.5 | 18 | 17 | 38.5 | 34.1 |
| ENPL_RAT | HSP90B1 | 742.6 | 492.2 | 25 | 16 | 29.6 | 23.5 |
| EPHA6_RAT | EPHA6 | 486.4 | 361.4 | 27 | 20 | 32.4 | 24.5 |
| FABPL_RAT | FABPL | 120.5 | 779.4 | 3 | 16 | 36.2 | 81.9 |
| G3P_RAT | GAPDH | 486.7 | 763 | 14 | 18 | 53.8 | 62.2 |
| OGA_RAT | MEGEA5 | 308.5 | 353.6 | 16 | 19 | 26.7 | 31.6 |
| PARK7_RAT | PARK7 | 173.3 | 187.5 | 4 | 10 | 28.6 | 51.3 |
| PRC2A_RAT | PRRC2A | 776.2 | 670.4 | 43 | 36 | 25.3 | 23.6 |
| SI1L1_RAT | SI1L1 | 575.9 | 672.1 | 32 | 37 | 27.9 | 30.7 |
| STIP1_RAT | STIP1 | 189.5 | 258.9 | 10 | 14 | 22.1 | 30 |
| SYPM_RAT | PARS2 | 171.2 | 183.4 | 9 | 10 | 32.6 | 46.3 |
| TBB4B_RAT | TUBB4B | 801.7 | 463.1 | 20 | 15 | 52.1 | 48.8 |
| TPP1_RAT | TPP1 | 99.3 | 109.3 | 5 | 6 | 9.9 | 11.7 |
| UBR4_RAT | UBR4 | 1,600.3 | 1,813.1 | 90 | 103 | 24.2 | 30.2 |
| UD2B2_RAT | UGT2B | 390.2 | 705.3 | 21 | 25 | 44.7 | 59.1 |